According to a Motilal Oswal Financial Services study, 27 out of 47 companies on the Nifty were trading above their 10-year average valuations. The valuations were measured based on the Price to Earnings (PE) Ratio and Price to Book (P/B).
Sun Pharma deal structurally strong, debt the only overhang: Amit Khurana
Market expert Amit Khurana offers insights on key corporate and regulatory developments. Sun Pharma’s acquisition is seen as strategically sound, though debt requires careful management.